Senior Director of U.S. Market Access and Reimbursement at RTI Health to Present at GTCbio's 2nd Annual Rediscovering Biomarkers Conference on July 10-11
Eric Faulkner, Senior Director of U.S. Market Access and Reimbursement at RTI Health to Present at GTCbio's 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA


    /Biotechnology News Articles/ - MONROVIA, CA, April 20, 2008 - Dr. Eric Faulkner, Senior Director of U.S. Market Access and Reimbursement at RTI Health will be speaking at GTCbio's 2nd Annual Rediscovering Biomarkers conference on July 10-11, 2008 in Boston, MA. Dr. Faulkner will present on "Capturing the Value of Biomarkers: The Necessity of Planning from a Reimbursement Perspective."
We are in the early days of an era where biomarkers are poised to redefine many aspects of health care practice and policy. More than virtually any other factor, reimbursement will play a pivotal role in the success of biomarker-based technologies. For rapidly evolving innovator diagnostics and treatments, it is clear that one-size-fits-all approaches are insufficient in an environment largely oriented towards characterizing the value of conventional treatments. What information are health decision makers looking for to characterize the value of biomarkers used in diagnostics and to inform treatment use or outcomes? What tools, metrics and processes are relevant and essential to pricing and reimbursement in the US? This session will explore current practice and policy issues associated with biomarkers in an environment increasingly focused on evidence-based and personalized health care, where reimbursement is a growing hurdle for new technology access and diffusion.
The 2nd Annual Rediscovering Biomarkers Conference will expose attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees will gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.

For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=124

Further Related Resources:


Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website